Co-Authors
This is a "connection" page, showing publications co-authored by Zihe Rao and Haitao Yang.
Connection Strength
1.592
-
Drug design targeting the main protease, the Achilles' heel of coronaviruses. Curr Pharm Des. 2006; 12(35):4573-90.
Score: 0.326
-
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors. Protein Cell. 2021 11; 12(11):877-888.
Score: 0.235
-
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. Nat Struct Mol Biol. 2020 06; 27(6):529-532.
Score: 0.220
-
Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020 05 15; 368(6492):779-782.
Score: 0.219
-
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 06; 582(7811):289-293.
Score: 0.219
-
Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J Virol. 2008 Mar; 82(5):2515-27.
Score: 0.093
-
Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10. J Virol. 2006 Aug; 80(16):7902-8.
Score: 0.085
-
Structural insights into SARS coronavirus proteins. Curr Opin Struct Biol. 2005 Dec; 15(6):664-72.
Score: 0.081
-
Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives. Nat Commun. 2021 05 24; 12(1):3061.
Score: 0.059
-
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020 06 19; 368(6497):1331-1335.
Score: 0.055